HomeAI · summaries
Storia in 9 fonti
New vaccines will blunt the impact of future Ebola outbreaks, scientists say | The National
Amid the spread of the virus in the Democratic Republic of Congo, vaccine development is being fast-tracked
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
newsbytesapp.com
3 Ebola vaccines being developed amid outbreak in Africa
Three vaccines are being developed to address a rare Ebola strain, which has already claimed nearly 250 lives and poses the risk of becoming the worst outbreak recorded.
- ·
dailymail.com
Race to develop ebola vaccines is ON: Three jabs in development
Experts have warned that the spread, caused by the Bundibugyo strain of the virus, could surpass the infamous outbreak of Ebola which killed more than 11,000 people between 2014…
- ·
gulfnews.com
Race to develop Ebola vaccine heats up
Global health groups race to develop a Bundibugyo Ebola vaccine as cases surge in DR Congo and Uganda, with WHO backing a leading rVSV candidate.
- ·
washingtonexaminer.com
Fewer Ebola cases in Congo than previously thought: WHO
Violence in the region has thwarted efforts to tackle Ebola, as Congo lacks the institutional capability to manage the crisis.
- ·
npr.org
What will it take to get a vaccine for the Ebola strain driving the current outbreak?
There is an effective vaccine for Ebola — but not for the variety spreading rapidly in the Democratic Republic of Congo. Trials are going on for several candidates. How long will…
- ·
aljazeera.com
What are the Ebola vaccines under research, and when will they be ready?
At least three vaccines are being funded, research being fast-tracked as the outbreak spreads faster than the response.
- ·
theguardian.com
The race to combat Ebola: what vaccines and treatments are being developed and how long will it take?
With the Bundibugyo strain of the disease spreading across the DRC and Uganda, scientists and researchers are trying to find rapid solutions
- ·
independent.co.uk
We talked to two scientists racing to find a new Ebola vaccine. Here’s what to know
The Oxford group is using ChADOx1, a viral-vector platform that formed the basis of the Oxford-AstraZeneca COVID-19 vaccine
- ·
thenationalnews.com
New vaccines will blunt the impact of future Ebola outbreaks, scientists say | The National
Amid the spread of the virus in the Democratic Republic of Congo, vaccine development is being fast-tracked